Fluid Pharma and Mikart Partnership: ODT microparticles improve acceptability in patients with Dysphagia

News
Article

Sponsored Content

Sustained Release Orally Disintegrating Tablets (ODTs) Comprising Coated Microparticles to Improve Acceptability in Patients with Dysphagia

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.